Platelet MPs obscure some EPC definitions

Mervin C Yoder1

  • 1Indiana University, IN, USA.

Blood
|July 18, 2009
PubMed

Insights

Contaminating platelet microparticles (MPs) can be mistakenly identified as endothelial progenitor cells (EPCs) in vitro assays. This uptake leads to significant misinterpretation of cell surface phenotype results.

Area of Science:

  • Cell biology
  • Hematology
  • Immunology

Background:

  • Endothelial progenitor cells (EPCs) are crucial for vascular repair and are typically identified by specific cell surface markers in vitro.
  • Commonly used in vitro assays for EPC identification may be susceptible to confounding factors.
  • Platelet-derived microparticles (MPs) are small vesicles released from platelets, known to interact with other cell types.

Discussion:

  • The study investigates a potential artifact in EPC identification assays.
  • It proposes that the observed cell surface phenotype of EPCs might be due to the uptake of platelet MPs by mononuclear cells.
  • This phenomenon could lead to a gross misinterpretation of the assay's results, overestimating EPC populations.

Key Insights:

  • The cell surface phenotype defining EPCs in a common in vitro assay may not represent true EPCs.
  • Uptake of contaminating platelet MPs by cultured mononuclear cells is identified as a likely source of this artifact.
  • This finding highlights a critical limitation in current EPC characterization methods.

Outlook:

  • Re-evaluation of current in vitro EPC identification protocols is necessary.
  • Development of more specific assays to distinguish true EPCs from MP-associated artifacts is recommended.
  • Further research should focus on the precise mechanisms of MP-EPC interaction and its physiological implications.